M. Markert et al. / Tetrahedron 60 (2004) 993–999
997
3.3.9. 3e,4a,5e-Trimethyl-2e,6e-diphenyl-tetrahydro-
pyran-4e-ol (2c). 300 mg 2c (25.3%) colourless solid
(procedure A); mp 160–162 8C (hexane/ethylacetate); IR
(neat) nmax 3478, 2974, 2882, 1495, 1453, 1381, 1312, 1208,
(neat) nmax 2917, 1712, 1602, 1494, 1452, 1103, 1067,
1
1028 cm21; H NMR d¼7.40–7.10 (10H, m, CHPh), 4.88
(1H, dd, J¼3.0, 10.9 Hz, H1), 2.72 (2H, d, J¼13.7 Hz, H4),
1.75 (1H, dd, J¼3.0, 13.2 Hz, H2), 1.69 (1H, dd, J¼10.9,
13.2 Hz, H2), 1.18 (3H, s, –CH3); 13C NMR d¼142.9, 137.7,
130.6, 128.7, 128.5, 128.2, 127.3, 126.9, (CHPh), 75.1, 70.5,
(C1, C3), 50.1, 45.1, (C2, C4), 29.1(–CH3); HRMS: calcd for
C17H16 (M-2H2O) 220.1252. Found: 220.1252 (M22H2O).
1
1069, 1026, 984 cm21; H NMR d¼7.36–7.12 (10H, m,
CHPh), 4.18 (2H, d, J¼10.6 Hz, H2, H6), 1.88 (2H, dq,
J¼7.2, 10.6 Hz, H3, H5), 1.18 (3H, s, –CH3), 0.64 (6H, d,
J¼7.2 Hz, –CH3); 13C NMR d¼141.0, 128.3, 127.8, 127.3,
(CHPh), 83.4, 73.9, (C2, C4, C6), 49.2, (C3, C5), 14.7, 10.4,
(3£–CH3); HRMS: calcd for C20H24O2 296.17763. Found:
296.17763.
3.3.14. 3e-Isopropyl-4a-methyl-2e,6e-diphenyl-tetra-
1
hydropyran-4e-ol (2f). H NMR d¼7.50–7.10 (10H, m,
CHPh), 4.54 (1H, dd, J¼2.6, 11.3 Hz, H6), 4.45 (1H, d,
J¼10.9 Hz, H2), 2.17 (1H, dqq, J¼7.2, 7.2, 9.4 Hz,
–CHMe2), 1.91 (1H, dd, J¼2.6, 12.8 Hz, H5), 1.88 (1H,
dd, J¼11.3, 12.8 Hz, H5), 1.81 (1H, dd, J¼9.4, 10.9 Hz,
H3), 1.51 (3H, s, –Me), 0.88 (3H, d, J¼7.2 Hz, –Me), 0.41
(3H, d, J¼7.2 Hz, –Me); 13C NMR d¼142.3, 141.4, 128.8,
128.3, 128.2, 128.1, 127.4, 125.9, 80.6, 77.2, 73.1 (C2, C4,
C6), 56.4, 51.6 (C3, C5), 24.5, 24.4, 22.7, 18.7.
The isomers 1c, 3c and 4c could not be separated by
chromatography. The ratio of these isomers was determined
by integration of important signals in the 1H and 13C NMR
spectra.
3.3.10. 3e,30a,4e-Trimethyl-2e,6e-diphenyl-tetrahydro-
pyran-4a-ol (1d). 755 g 1d (63.7%) as colourless crystals
(procedure A); mp 129–130 8C (hexane/ethylacetate); IR
(neat) nmax 3505, 2976, 1686, 1454, 1363, 1287, 1201, 1144,
3.3.15. 9a-Methyl-2e,4e-diphenyl-3-oxa-bicyclo[3.3.1]-
nonan-9e-ol (3g). 283 mg 3g (23%) as a colourless oil
(procedure A); IR (neat) nmax 3454, 2960, 1738, 1372, 1215,
1141, 1050 cm21; 1H NMR d¼7.50–7.10 (10H, m, CHPh),
5.09 (1H, m, H2, H4), 2.10–1.00 (11H, m, H1, H5, H6, H7,
H8, 2CH3); 13C NMR d¼141.8, 128.1, 126.7, 125.2,
(CHPh), 79.0, 71.8, (C2, C4, C6), 45.4, (C3, C5), 26.6, 20.4,
(3£–CH2), 19.0 (–CH2); HRMS: calcd for C21H24O2
308.1776. Found: 308.1776.
1
1119, 1091, 1058, 1039, 1007 cm21; H NMR d¼7.39–
7.11 (10H, m, CHPh), 4.91 (1H, dd, J¼2.6, 12.1 Hz, H6),
4.89 (1H, s, H2), 1.95 (1H, dd, J¼12.1, 13.9 Hz, H5), 1.64
(1H, dd, J¼2.6, 13.9 Hz, H5), 1.14 (3H, s, –CH3), 0.85 (3H,
s, –CH3), 0.75 (3H, s, –CH3); 13C NMR d¼143.2, 139.6,
128.3, 128.2, 127.2, 127.1, 126.9, 125.6, (CHPh), 82.0, 75.4,
73.7, (C2, C4, C6), 44.4, 40.8, (C3, C5), 25.6, 18.6, 17.9, (3£–
CH3);HRMS:calcdforC20H24O2 296.1776.Found:296.1776.
3.3.11. 3e,30a,4a-Trimethyl-2e,6e-diphenyl-tetrahydro-
pyran-4e-ol (3d). 150 mg 3d (12.7%) as a colourless oil
(procedure A); IR (neat) nmax 3484, 2975, 1720, 1495, 1453,
3.3.16. 9e-Methyl-2e,4e-diphenyl-3-oxa-bicyclo[3.3.1]-
nonan-9a-ol (4g). 230 mg 4g (18.7%) as colourless crystals
(procedure A); mp 132–133 8C (hexane/ethylacetate); IR
(neat) nmax 3251, 2925, 1738, 1496, 1449, 1380, 1207, 1139,
1
1385, 1102, 1081, 1066, 1036 cm21; H NMR d¼7.43–
1
7.14 (10H, m, CHPh), 4.65 (1H, dd, J¼2.6, 12.1 Hz, H6),
4.50 (1H, s, H2), 2.05 (1H, dd, J¼12.1, 13.6 Hz, H5), 1.74
(1H, dd, J¼2.6, 13.6 Hz, H5), 1.52 (3H, s, –CH3), 0.93 (3H,
s, –CH3), 0.78 (3H, s, –CH3); 13C NMR d¼142.5, 139.1,
128.3, 128.1, 127.4, 127.3, 127.2, 125.7, (CHPh), 84.1, 77.2,
73.5, (C2, C4, C6), 45.9, 41.8, (C3, C5), 23.3, 19.6, 16.0,
(3£–CH3); HRMS: calcd for C20H24O2 296.1776. Found:
296.1776.
1064 cm21; H NMR d¼7.42–7.11 (10H, m, CHPh), 5.50
(2H, m, H2, H4), 2.09–1.13 (11H, m, H1, H5, H6, H7, H8,
–CH3); 13C NMR d¼142.5, 127.9, 126.3, 125.2, (CHPh),
76.5, 72.4, (C2, C4, C9), 45.4, (C1, C5), 27.9, 23.0, (C6, C7,
C8), 19.3, (–CH3); HRMS: calcd for C21H24O2 308.1776.
Found: 308.1776.
3.3.17. anti-2-Hydroxybenzyl-1-methyl-cyclohexan-1-ol
(5g).6 147 mg 5g (16.7% yield) as a colourless oil
(procedure A); 1H NMR d¼7.30–7.10 (5H, m, CHPh),
4.46 (1H, d, J¼10.2 Hz, CHOH), 1.72–0.68 (12H, m, H2,
H3, H4, H5, H6, –CH3); 13C NMR d¼142.4, 128.3, 127.8,
127.3, (CHPh), 78.7, 74.5, (C1, CHOH), 52.1, 42.2, (C2,
C6), 27.0, 25.5, 23.6, 21.0, (C3, C4, C5, –CH3).
3.3.12. 4e-Methyl-2e-3e,6e-triphenyl-tetrahydropyran-
4a-ol (4e). 250 mg 4e (18.2%) as a colourless oil (procedure
A); IR (neat) nmax 3479, 3032, 1719, 1492, 1453, 1116,
1059, 1022 cm21; 1H NMR d¼7.43–7.01 (15H, m, CHPh),
5.17 (1H, d, J¼10.6 Hz, H2), 5.12 (1H, dd, J¼2.3, 11.3 Hz,
H6), 2.88 (1H, d, J¼10.6 Hz, H3), 2.05 (1H, dd, J¼2.3,
13.6 Hz, H5), 1.88 (1H, dd, J¼11.3, 13.6 Hz, H5), 1.03 (3H,
s, –CH3); 13C NMR d¼142.8, 141.0, 137.5, 130.6, 130.5,
128.6, 128.3, 128.2, 127.3, 127.0, 126.5, 125.9, (CHPh),
79.6, 75.1, 70.4, (C2, C4, C6), 58.5, 47.3, (C3, C5), 29.9,
(–CH3); HRMS: calcd for C24H24O2 344.1776. Found:
344.1776.
3.3.18. 3e-Chlor-4a-methyl-2e,6e-diphenyl-tetrahydro-
pyran-4e-ol (2h). 470 mg 2h (38.8%) as a colourless oil
(procedure B); IR (neat) nmax 3279, 1690, 1602, 1495, 1449,
1300, 1094, 1065, 1028 cm21
;
1H NMR d¼7.45–7.12
(10H, m, CHPh), 4.65 (1H, dd, J¼2.3, 11.7 Hz, H6), 4.42
(1H, d, J¼10.6 Hz, H2), 3.99 (1H, d, J¼10.6 Hz, H3), 2.13
(1H, dd, J¼2.3, 13.6 Hz, H5), 2.06 (1H, dd, J¼11.7,
13.6 Hz, H5), 1.58 (3H, s, CH3); 13C NMR d¼140.7, 138.6,
128.6, 128.4, 128.3, 127.9, 127.7, 125.9, (CHPh), 81.7, 71.9,
71.1, (C2, C3, C4, C6), 47.7, (C5), 21.9 (–CH3); HRMS:
calcd for C18H19ClO2 302.1074. Found: 302.1072.
The isomer 2e could not be separated by column
chromatography. The ratio of the isomers 2e and 4e was
determined by integration of important signals in the 1H and
13C NMR spectra.
3.3.13. syn-3-Methyl-1,4-diphenyl-butan-1,3-diol (5e).
350 mg 5e (34.2%) as a colourless oil (procedure A); IR
3.3.19. 8a-Methyl-2e,4e-diphenyl-3-oxa-bicyclo[3.2.1]-
octan-8e-ol (3i). 550 mg 3i (46.7%) as a colourless oil